CML Rheumatology - 2010 - A Phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus


Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. - May, 2012
Abatacept in subjects who switch from intravenous to subcutaneous therapy: results from the Phase IIIb ATTUNE study. - April, 2012
Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays. - March, 2012
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised Phase 2 trial. - February, 2012
Erosive hand osteoarthritis: its prevalence and clinical impact in the general population and symptomatic hand osteoarthritis. - January, 2012
Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency. - December, 2011
Safety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritis. - November, 2011
Serum free light chains as biomarkers for systemic lupus erythematosus disease activity. - October, 2011
Uveitis in adult patients with rheumatic inflammatory autoimmune diseases at a tertiary-care hospital in Mexico City. - September, 2011
Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation. - August, 2011
Joint lavage associated with triamcinolone hexacetonide injection in knee osteoarthritis: a randomized double-blind controlled study. - July, 2011
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. - June, 2011
Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. - May, 2011
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs - April, 2011
Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine - March, 2011
Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable – clinical, serological characteristics and outcomes in a large cohort of Italian patients - February, 2011
Ultrasound elastography assessment of skin involvement in systemic sclerosis: lights and shadows - January, 2011
Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage - December, 2010
Will this patient develop persistent disabling low back pain? - November, 2010
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria - October, 2010
A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia - September, 2010
Preventing tuberculosis in children receiving anti-TNF treatment - August, 2010
Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis - July, 2010
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review - June, 2010
Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis - May, 2010
Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial - April, 2010
Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin - March, 2010
A Phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus - February, 2010
Ankle disease in juvenile idiopathic arthritis: ultrasound findings in clinically swollen ankles - January, 2010
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe. - December, 2009
Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. - November, 2009
Geographic variation in rheumatoid arthritis incidence among women in the United States. - October, 2009

© Remedica 2012. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the manufacturer’s prescribing information.

Produced and published by Remedica Medical Education and Publishing Limited.

May 24, 2012

CLOSE

To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader.

Produced and published by Remedica Medical Education and Publishing Limited.

» Contact us

CML Rheumatology

» Advanced search

Paper of the Month - February, 2010

A Phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

Wallace DJ, Stohl W, Furie RA et al.

View Archive »

READER POLL

WEB LINKS

Post Page On

SUBMIT AN ARTICLE


0 rating

May 24, 2012 CLOSE To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader. Produced and published by Remedica Medical Education and Publishing Limited. » Contact us

CML Rheumatology » Advanced search